Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.73 |
| ▸ | TSHR | P16473 | 1/20 | 0.73 |
| ▸ | PLA2G4B | P0C869 | 5/20 | 0.71 |
| ▸ | THRA | P10827 | 4/20 | 0.68 |
| ▸ | THRB | P10828 | 4/20 | 0.68 |
| ▸ | RARB | P10826 | 3/20 | 0.67 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.63 |
| ▸ | MMP1 | P03956 | 1/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.63 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7913066 | 0.98 | TP53 (0.70) | TP53TSHRPLA2G4BTHRATHRB | |
| SCHEMBL7636635 | 0.95 | L3MBTL1 (0.69) | TP53TSHRPLA2G4BTHRATHRB | |
| SCHEMBL2355796 | 0.92 | MAPT (0.66) | TP53TSHRPLA2G4BTHRATHRB | |
| SCHEMBL2356406 | 0.92 | MAPT (0.66) | TP53TSHRPLA2G4BTHRATHRB | |
| SCHEMBL11236261 | 0.92 | TP53 (0.71) | TP53TSHRPLA2G4BTHRATHRB | |
| SCHEMBL11802071 | 0.92 | TP53 (0.67) | TP53TSHRPLA2G4BTHRATHRB | |
| SCHEMBL2350770 | 0.91 | MAPT (0.68) | TP53TSHRPLA2G4BTHRATHRB | |
| SCHEMBL3031625 | 0.90 | TP53 (0.64) | TP53TSHRPLA2G4BTHRATHRB | |
| SCHEMBL17284859 | 0.90 | TP53 (0.73) | TP53TSHRPLA2G4BTHRATHRB | |
| SCHEMBL13267786 | 0.90 | TP53 (0.73) | TP53TSHRPLA2G4BTHRATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050245673-A1 | Care and/or make-up cosmetic composition structured with silicone polymers and organogelling agents, in rigid form | L'OREAL S.A. (FR) | 2005-11-03 | — | — | US | claimed |
| CN-1658819-A | Care and/or make-up cosmetic composition structured with silicone polymers and organogelling agents, in rigid form | OREAL (FR) | 2005-08-24 | — | — | CN | claimed |
| EP-1515684-A2 | CARE AND/OR MAKE-UP COSMETIC COMPOSITION STRUCTURED WITH SILICONE POLYMERS AND ORGANOGELLING AGENTS, IN RIGID FORM | L'OREAL (FR) | 2005-03-23 | — | — | EP | claimed |
| WO-2003105788-A2 | CARE AND/OR MAKE-UP COSMETIC COMPOSITION STRUCTURED WITH SILICONE POLYMERS AND ORGANOGELLING AGENTS, IN RIGID FORM | L'OREAL (FR) | 2003-12-24 | — | — | WO | claimed |
| US-9180195-B2 | Controlled release gels | NANO FIBER MATRICES B.V. (NL) | 2015-11-10 | — | — | US | disclosed |
| US-7820146-B2 | Care and/or make-up cosmetic composition structured with silicone polymers and organogelling agents, in rigid form | L'OREAL S.A. (FR) | 2010-10-26 | — | — | US | disclosed |
| US-20090169498-A1 | Controlled Release Gels | NANO FIBER MATRICES B.V. (NL) | 2009-07-02 | — | — | US | disclosed |
| US-20080057011-A1 | Composition structured with a polymer containing a heteroatom and an Organogelator | L'OREAL S.A., | 2008-03-06 | — | — | US | disclosed |
| US-20050245673-A1 | Care and/or make-up cosmetic composition structured with silicone polymers and organogelling agents, in rigid form | L'OREAL S.A. (FR) | 2005-11-03 | — | — | US | disclosed |
| CN-1658819-A | Care and/or make-up cosmetic composition structured with silicone polymers and organogelling agents, in rigid form | OREAL (FR) | 2005-08-24 | — | — | CN | disclosed |
| US-20050158260-A1 | Cosmetic composition containing a polyorganosiloxane polymer | L'OREAL (FR) | 2005-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080057011-A1 | Composition structured with a polymer containing a heteroatom and an Organogelator | CUTA, FABP4, PARG | TP53 1092/4885TSHR 3188/4885PLA2G4B 750/4885 |
| US-20090169498-A1 | Controlled Release Gels | PGA5, SUCLG1, CDC37 | TP53 2819/4885TSHR 3402/4885PLA2G4B 877/4885 |
| US-20050158260-A1 | Cosmetic composition containing a polyorganosiloxane polymer | SQLE, CUTA, FDFT1 | TP53 720/4885TSHR 3496/4885PLA2G4B 1218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.